Analysis of the expenses on pharmaceutical provision of newborns in Ukraine
DOI:
https://doi.org/10.24959/sphhcj.19.141Keywords:
pharmaceutical provision, medicines, parapharmaceutical products, expenses, newborn babiesAbstract
Aim. To analyze the expenses on pharmaceutical provision of newborns in Ukraine.
Materials and Methods. Data from the State Register of Medicines of Ukraine, the electronic database of the Morion information retrieval program and the price lists of the weekly “Pharmacy” as of December 15, 2018; logical, system-analytical, mathematical-statistical and comparative methods of analysis were used.
Results. The analysis of the list of pharmaceutical provision for newborns has shown that it consists of approximately 80% of the parafarmaceutical products and 20% of medicines. A comparative analysis of the effectiveness and availability of pharmaceutical supply of newborns in Ukraine has demonstrated that the average total cost is about 12600 UAH per month, and the availability factor is 1.39.
Conclusions. The results of the analysis conducted can be used when forming the financial aid for newborns in Ukraine to improve the quality of pharmaceutical provision, expand the range of products needed, and increase their availability.
References
Health 2020: Fundamentals of the European Strategy to support the actions of the entire state and society in the interests of health and well–being. (2012). – Copenhagen: WHO WHO,.
Ustiuhova, A. M. (2009). Metodicheskie podkhody k sovershenstvovaniiu organizatsii lekarstvennogo obespecheniia novorozhdennykh detei v usloviiakh statcionara [Methodical approaches to improving the organization of drug provision of newborns in the hospital]. Extended abstract of candidate’s thesis. Moscow, 24.
Bazargani, Y. T., Ewen, M., Boer, A. de, Leufkens, H. G. M., Mantel–Teeuwisse, A. K. (2014). Essential Medicines Are More Available than Other Medicines around the Globe. PLoS ONE, 9 (2), e87576. doi: 10.1371/journal.pone.0087576.
Nemchenko, A. S., Kubarieva, I. V., Kosiachenko, K. L. (2009). Zaporozhskyi medytsynskyi zhurnal, 5, 122–125.
Wendykowska, K., Władysiuk, M., Bondaryk, K., Budasz–Świderska, M., Ofierska–Sujkowska, G., Łanda, K. (2013). Proceeding from Praktychni aspekty vprovadzhennia otsinky tekhnolohii okhorony zdorovia v Ukraini: materialy mizhnarodnoi naukovo–praktychoi konferentsii (5–6 bereznia 2013 r.) (pp. 70–82). Kyiv.
Belousov, Yu. B., Gratcianskaia, A. N. (2015). Farmateka, 1 (155), 15–18.
Vorobev, P. A. (2017). Farmatsevticheskii vestnik, 9 (456), 6.
Baranov, A. A., Gorelov, A. B., Zadorozhnaia, V. I. at al. (2017). Pediatricheskaia farmakologiia, 4 (1), 6–18.
Kukes, V. G., Volodin, H. H., Sychev, D. A., Koman, I. E. (2006). Vestnik pediatrii, farmakologii i nutritciologii, 3 (1), 16–23.
Kirsanov, D. (2016). Ezhenedelnik “Apteka”, 1023 (2). Available at: http://www.apteka.ua/article/358052.
Kirsanov, D. (2016). Ezhenedelnik “Apteka”, 1040 (19). Available at: http://www.apteka.ua/article/372763
State Statistics Service of Ukraine. Available at: http://www.ukrstat.gov.ua/
Downloads
Published
Issue
Section
License
Copyright (c) 2019 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).